Delivery Order SPE2DB25D3109-SPE2DB26FP4NV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,352.44 to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a pharmaceutical product used primarily for neuromuscular conditions. The contract was awarded on September 18, 2025, with an ultimate completion date of October 9, 2025, under firm fixed-price terms with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $43,134 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a pharmaceutical product used in medical treatments. This non-set-aside competitive award was issued on August 14, 2025, with an ultimate completion date of September 5, 2025. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Xeomin 100 unit vials valued at $6,704.88 with a firm fixed price structure. The order is scheduled for completion by August 19, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $3,352.44 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Xeomin 100 unit vials, with performance completion scheduled for October 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a $93,868.32 firm fixed-price delivery order for 200-unit vials of Xeomin on October 17, 2025, with an ultimate completion date of November 7, 2025. This non-competitive delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp was awarded a $5,587.40 delivery order by the Defense Logistics Agency (DLA) on October 23, 2025, for the supply of 100-unit vials of Xeomin. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 14, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, demonstrating AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,234.96 to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Xeomin 100 unit vials. The contract utilizes firm fixed pricing and is scheduled for completion by November 7, 2025. This is an unset-aside, competitively awarded delivery order, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,766.46 to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin on October 24, 2025, with an ultimate completion date of November 17, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through an open process. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $5,028.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Xeomin 100 Unit Vials, with completion targeted for October 7, 2025. This competitively awarded contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $33,524.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Xeomin 100 unit vials, with an ultimate completion date of October 8, 2025. This non-set-aside contract is being performed at the awardee's Conshohocken, Pennsylvania location and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen is a major pharmaceutical...
- SPE2DB25D3109Indefinite Delivery Contract
- SPE2DB25D3109-SPE2DB26FP4NVDelivery Order
The Defense Logistics Agency awarded a $1,676.22 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a pharmaceutical product used for neurological and aesthetic applications. This firm fixed price, non-set-aside contract was awarded on October 27, 2025, with an ultimate completion date of November 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA contract demonstrates AmerisourceBergen's established capability and critical role as a primary pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/27/25 |